S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Stock market today: Wall Street heads for gains, but not enough to salvage a big September slide
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nursing Home REITs: The Surprise Heroes of High Yield Investing
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Justice Department Is Suing eBay, Alleging Unlawful Sales of Over 371,000 Products
Liverpool owner FSG announces minority investment by New York equity firm
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Stock market today: Wall Street heads for gains, but not enough to salvage a big September slide
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nursing Home REITs: The Surprise Heroes of High Yield Investing
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Justice Department Is Suing eBay, Alleging Unlawful Sales of Over 371,000 Products
Liverpool owner FSG announces minority investment by New York equity firm
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Stock market today: Wall Street heads for gains, but not enough to salvage a big September slide
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nursing Home REITs: The Surprise Heroes of High Yield Investing
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Justice Department Is Suing eBay, Alleging Unlawful Sales of Over 371,000 Products
Liverpool owner FSG announces minority investment by New York equity firm
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Stock market today: Wall Street heads for gains, but not enough to salvage a big September slide
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Nursing Home REITs: The Surprise Heroes of High Yield Investing
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Justice Department Is Suing eBay, Alleging Unlawful Sales of Over 371,000 Products
Liverpool owner FSG announces minority investment by New York equity firm
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
NASDAQ:XBIT

XBiotech (XBIT) Earnings Date, Estimates & Call Transcripts

$4.05
+0.03 (+0.75%)
(As of 09/28/2023 ET)
Compare
Today's Range
$3.91
$4.12
50-Day Range
$4.02
$5.81
52-Week Range
$3.00
$6.69
Volume
27,582 shs
Average Volume
20,715 shs
Market Capitalization
$123.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Skip Charts & View Estimated and Actual Earnings Data

XBIT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XBIT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

XBIT Earnings Date and Information

XBiotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 4th, 2023 based off prior year's report dates.

XBiotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/4/2023
Estimated)
------- 
11/9/2022Q3 2022-($0.42)($0.42)($0.42)-$1.68 million
8/10/2022Q2 2022-($0.38)($0.38)($0.38)-$1.53 million
5/10/2022Q1 2022-($0.18)($0.18)($0.18)-$0.50 million
3/15/2022Q4 2021-($0.21)($0.21)($0.21)-$4.50 million
11/9/2021Q3 2021-($0.11)($0.11)($0.11)-$4.52 million
8/9/2021Q2 2021-($0.17)($0.17)($0.17)-$4.53 million
5/10/2021Q1 2021-($0.09)($0.09)($0.09)-$4.85 million
3/16/2021Q4 2020-($0.06)($0.06)($0.06)-$0.01 million
11/9/2020Q3 2020-($0.09)($0.09)($0.09)-$10.55 million












XBiotech Earnings - Frequently Asked Questions

When is XBiotech's earnings date?

XBiotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 4th, 2023 based off last year's report dates. Learn more on XBIT's earnings history.

How much revenue does XBiotech generate each year?

XBiotech (NASDAQ:XBIT) has a recorded annual revenue of $4.01 million.

How much profit does XBiotech generate each year?

XBiotech (NASDAQ:XBIT) has a recorded net income of -$32.90 million. XBIT has generated -$1.19 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:XBIT) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -